Skip to main content

Controlled withdrawal of selective serotonin reuptake inhibitor drugs in elderly patients in nursing homes with no indication of depression

Abstract

Objective

The aim of the investigation was to study the effects of withdrawing selective serotonin reuptake inhibitor (SSRI) drugs in nursing home patients, who had no documented diagnosis or symptoms of depression.

Setting

The setting of the study was in 11 nursing homes in the county of Stockholm, Sweden.

Participants

Participants were patients without dementia or history of depression who had received treatment with SSRI drugs for more than 6 months and who had no indications of anxiety disorder or major depression

Design

The included patients (n=70) were randomized to either the intervention group (withdrawal of SSRI) or the control group (no change in treatment), 35 patients to each group.

Main outcome measures

The patients were subjected to assessment using the following instruments: Montgomery-Åsberg depression rating scale, global assessment for functioning, health index and a symptom assessment form. Assessment was made at the start of the study and at the 3-month and 6-month follow-ups.

Results

We found no significant difference between the intervention and control groups in any outcome measure.

Conclusion

Treatment with SSRI drugs in patients without clinical major depression or anxiety disorder is often unjustified and should be discontinued.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Pitkala KH, Strandberg TE, Tilvis RS (2001) Is it possible to reduce polypharmacy in the elderly? A randomized, controlled trial. Drugs Aging 18:143–149

    CAS  PubMed  Google Scholar 

  2. Barat I, Andreasen F, Damsgaard EM (2000) The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 56:501–509

    Google Scholar 

  3. Furniss L, Lloyd Craig K, Burns A (1998) Medication use in nursing homes for elderly people. Int J Geriatr Psychiatry 13:433–439

    Article  CAS  PubMed  Google Scholar 

  4. Bhatia SC, Bathia SK (1997) Major depression: selecting safe and effective treatment. Am Fam Physician 55:1683–1698

    CAS  PubMed  Google Scholar 

  5. Muijser RB, Plosker GL, Noble S (2002) Sertraline: a review of its use in the management of major depressive disorder in elderly patients. Drugs Aging 19:377–392

    PubMed  Google Scholar 

  6. Serby M, Yu M (2003) Overview. Depression in the elderly. Mt Sinai J Med 70:38–44

    PubMed  Google Scholar 

  7. Barkin RL, Schwer WA, Barkin SJ (2000) Recognition and management of depression in primary care: a focus on the elderly. A pharmacotherapeutic overview of the selection process among the traditional and new antidepressant. Am J Ther 7:205–226

    CAS  PubMed  Google Scholar 

  8. Cole MG, Elie LM, McCuster J, Bellavance F, Mansour A (2000) Feasibility and effectiveness of treatment for depression in elderly medical inpatients: a systematic review. Int Psychogeriatr 12:453–461

    CAS  PubMed  Google Scholar 

  9. Steiner D, Marcopulos B (1991) Depression in the elderly. Characteristics and clinical management. Nurs Clin North Am 26:585–600

    CAS  PubMed  Google Scholar 

  10. Bell M, Goss AJ (2001) Recognition, assessment and treatment of depression in geriatric nursing home residents. Clin Excell Nurse Pract 5:26–36

    CAS  PubMed  Google Scholar 

  11. Nyth AL, Gottfries CG, Lyby K, Smedegaard-Andersen L, Gylding-Sabroe J, Kristensen M et al (1992) A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand 86:138–145

    CAS  PubMed  Google Scholar 

  12. Kates N, Crustolo AM, Farrar S, Nikolaou L (2002) Counselors in primary care: benefits and lessons learned. Can J Psychiatry 47:857–862

    PubMed  Google Scholar 

  13. Scott J, Thorne A, Horn P (2002) Quality improvement report: effect of a multifaceted approach to detecting and managing depression in primary care. BMJ 26:951–954

    Article  Google Scholar 

  14. American Psychiatric Association. (2000) Diagnostic and statistical manual of mental disorders: DSM-IV, 4th edn. American Psychiatric Association, Washington, DC

    Google Scholar 

  15. Mottram P, Wilson K, Copeland J (2000) Validation of the Hamilton Depression Rating Scale and Montgomery and Åsberg Rating Scales in terms of AGECAT depression cases. Int J Geriatr Psychiatry 15:1113–1193

    Article  CAS  PubMed  Google Scholar 

  16. Brown MN, Lapane KL, Luisi AF (2002) The management of depression in older nursing home residents. J Am Geriatr Soc 50:69–76

    Article  PubMed  Google Scholar 

  17. Montgomery SA, Åsberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:383–389

    Google Scholar 

  18. Bodlund O, Kullgren G, Ekselius L, Lindström E, von Knorring L (1994) Axis V—Global Assessment of Functioning. Evaluation of a self-report version. Acta Psychiatr. Scand. 90:342–347

  19. Startup M, Jackson MC, Bendix S (2002) The concurrent validity of the Global Assessment of Functioning (GAF). Br J Clin Psychol 41:417–422

    Article  PubMed  Google Scholar 

  20. Forsberg C, Björvell H (1993) Swedish population norms for the GHRI, HI and STAI-state. Qual Life Res 2:349–356

    CAS  PubMed  Google Scholar 

  21. Medical Products Agency’s Code of Statutes (2001) LVFS 12 ISSN 1101–5225

  22. Muijsers RB, Plosker GL, Noble S (2002) Spotlight on sertraline in the management of major depressive disorder in elderly patients. CNS Drugs 16:789–794

    PubMed  Google Scholar 

  23. Ulfvarson J, Adami J, Ullman B, Wredling R, Reilly M, von Bahr C (2003) Randomized controlled intervention in cardiovascular drug treatment in nursing homes. Pharmacoepidemiol Drug Safety 12:589–593

    Article  Google Scholar 

  24. McDonald WM, Salzman C, Schatzberg AF (2002) Depression in the elderly. Psychopharmacol Bull 36[Suppl 2]:121–122

  25. Ekselius L, von Knorring L, Eberhard G (1997) A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice. Int Clin Psychopharmacol 12:323–331

    CAS  PubMed  Google Scholar 

  26. Stahl SM (2000) Placebo-controlled comparison of the selective serotonin reuptake inhibitor citalopram and sertraline. Biol. Psychiatry 48:894–901

    Article  CAS  Google Scholar 

  27. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N (1998) Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351:1303–1307

    CAS  PubMed  Google Scholar 

  28. Pacher P, Ungvari Z (2001) Selective serotonin-reuptake inhibitors antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels. Medical Hypotheses 57:469–471

    Article  CAS  PubMed  Google Scholar 

  29. Movig KL, Leufkens HG, Belitser SV, Lenderink AW, Egberts AC (2002) Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiol. Drug Safety 4:271–279

    Article  Google Scholar 

  30. Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH (2003) Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 163:59–64

    Article  CAS  PubMed  Google Scholar 

  31. Movig KL, Leufkens HG, Lenderink AW, van den Akker VG, Hoidiamont PP, Goldschmidt HM, Egberts AC (2002) Association between antidepressant drug use and hyponatraemia: a case-control study. Br J Clin Pharmacol 53:363–369

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to The Swedish Foundation for Health Care Sciences and Allergy Research and the Federation of County Councils, Stockholm County Council, R&D Department. We also thank Jan Golebiowski, M.D., for assessing the patients in the follow-up.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Johanna Ulfvarson.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ulfvarson, J., Adami, J., Wredling, R. et al. Controlled withdrawal of selective serotonin reuptake inhibitor drugs in elderly patients in nursing homes with no indication of depression. Eur J Clin Pharmacol 59, 735–740 (2003). https://doi.org/10.1007/s00228-003-0687-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-003-0687-y

Keywords

  • SSRI drugs
  • Nursing homes
  • Withdrawal